Mayo Clinic study finds no survival benefit from longer multiple myeloma maintenance therapy
Rochester, Minn. — A major U.S.-led cooperative group clinical trial coordinated by Mayo Clinic researchers has found that extending maintenance ...
Rochester, Minn. — A major U.S.-led cooperative group clinical trial coordinated by Mayo Clinic researchers has found that extending maintenance ...
In a groundbreaking phase 2 clinical trial, researchers have demonstrated the efficacy of olaparib, a PARP inhibitor, in treating metastatic ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine